Intrinsic Value of S&P & Nasdaq Contact Us

Hepion Pharmaceuticals, Inc. HEPA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$70.00
+145733.3%

Hepion Pharmaceuticals, Inc. (HEPA) has 7 identified peers for comparison in the Healthcare sector. Peers include AVRO, CWBR, EFTR, ELEV, ENVB, OCEA and others.

HEPA has a market capitalization of $557.78K, compared to an average peer market cap of $57.33M. HEPA is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message